SCHEMBL63769

SCHEMBL63769

CCOC(=O)CCCCCCCCCCCCCC[PH](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.51
CYP4A11 Q02928 2/20 0.51
ALDH1A1 P00352 2/20 0.50
TBXAS1 P24557 3/20 0.46
CYP3A4 P08684 2/20 0.46
NAMPT P43490 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALOX5 P09917 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TOP2A P11388 1/20 0.45
FAAH O00519 2/20 0.44
POLB P06746 1/20 0.44
LTA4H P09960 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13783861 1.00 CYP4F2 (0.51) CYP4F2CYP4A11ALDH1A1TBXAS1CYP3A4
SCHEMBL12824143 1.00 CYP4F2 (0.51) CYP4F2CYP4A11ALDH1A1TBXAS1CYP3A4
SCHEMBL14423636 1.00 CYP4F2 (0.51) CYP4F2CYP4A11ALDH1A1TBXAS1CYP3A4
SCHEMBL8374043 0.98 CYP4F2 (0.52) CYP4F2CYP4A11ALDH1A1TBXAS1CYP3A4
Hydrochloric Acid SCHEMBL28126868 0.97 CYP4F2 (0.51) CYP4F2CYP4A11ALDH1A1TBXAS1CYP3A4
SCHEMBL63753 0.94 CYP4F2 (0.50) CYP4F2CYP4A11ALDH1A1TBXAS1CYP3A4
Bromide SCHEMBL27496529 0.92 CYP4F2 (0.49) CYP4F2CYP4A11ALDH1A1TBXAS1CYP3A4
SCHEMBL16381841 0.88 LTA4H (0.54) CYP4F2CYP4A11ALDH1A1CYP3A4NAMPT
SCHEMBL9466644 0.87 SMN1; SMN2 (0.50) CYP4F2CYP4A11ALDH1A1CYP3A4CYP2D6
Bromide SCHEMBL10944555 0.86 SMN1; SMN2 (0.49) CYP4F2CYP4A11ALDH1A1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129552-B2 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2012-03-06 US disclosed
US-20080214849-A1 PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSHAFTEN E.V. (DE) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214849-A1 PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS PHOSPHO1, PLTP, SGMS1 CYP4F2 1638/4885CYP4A11 2761/4885ALDH1A1 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.